Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma

• Status: Completed
• Trial end date: 2000-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was evaluation the efficacy of antiepileptic drug carbamazepine in the treatment of mild-to-severe bronchial asthma.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre of Chinese Medicine, Georgia
• Collaborator: Rea Rehabilitation Centre, Georgia
• Treatments: Carbamazepine

Criteria

Inclusion Criteria:

• Out patients

• Bronchial asthma has been known at least for 1 year

• Absence of long-term remissions of asthma (lasting more than 1 month)

• Poorly controlled asthma, due to various reasons

• Non-smokers

Exclusion Criteria:

• Presence of concomitant acute or chronic severe diseases

• Abnormal baseline haematology, blood chemistry or urinalysis

• Allergy or adverse reactions to investigational drug

• Age younger than 16 years old

• Long-term history of smoking

• Pregnancy or lactating